The high recolonization rate after monotherapy of Helicobacter pylori-positive gastritis may be due to insufficient local drug concentrations. To investigate the role of local diffusion, we measured levels of amoxicillin, a drug with good in vitro activity against H. pylori, in the mucosa and serum. One gram of amoxicillin was given to healthy volunteers as a tablet (n = 6) or as water-dissolved, fizzing "Tab" (n = 6). Gastroscopy with biopsies from the antrum, corpus, and fundus was performed at 30, 60, and 90 min. Concentrations in the mucosa were measured after homogenization with the agar diffusion method using BaciUlus subtilis as the biological indicator. Serum samples, taken basally and every 15 min, were analyzed by high-pressure liquid chromatography. Drug levels in the fundus and corpus remained far below those in the antrum for both application forms. The highest concentrations were reached after 30 min, with bactericidal levels in the antrum in two of six subjects who took the tablet form and five of six subjects who used Tabs. At 60 and 90 min, almost all values were below the MBC for 90% of the strains tested. The concentrations in serum, however, rose continuously, to reach a maximum after 75 or 90 min. These results show that incomplete elimination may be due to subbactericidal concentrations of antibiotics with high in vitro efficiency at the desired site of action in vivo and that local diffusion in the mucosa is essential for therapeutic effectiveness against H. pylor.
Worldwide and in all age groups, Helicobacterpylori is the major etiologic factor in chronic active antral gastritis (8, 9, 20, 28) . There is also convincing evidence that H. pylon plays an important role in duodenal ulcer disease (2, 5, 12) , especially since eradication of the bacterium is associated with a significantly lower recurrence rate compared with H2 receptor blocker therapy (6, 13, 19) . Moreover, in up to 70% of patients with nonulcer dyspepsia, H. pylon-positive active antral gastritis can be diagnosed (18, 25) , and although controversy about the clinical relevance of chronic gastritis remains, several investigators have found that these patients profit from elimination of H. pylon in terms of symptomatic improvement (14, 26) . Bismuth salts, like colloidal bismuth subcitrate, and a variety of antibiotic drugs are able to eliminate the bacterium from the antral mucosa (15, 23) , but recolonization within 1 month after therapy is the rule (24, 25) . The reason for this incomplete elimination has not been sufficiently elucidated; it may be due either to reinfection from a bacterial reservoir in the upper gastrointestinal tract or to subbactericidal drug concentrations at the desired site of action during therapy. To investigate the latter possibility, we measured gastric mucosal concentrations of amoxicillin, a drug with excellent in vitro activity against H. pylori, given in the usual therapeutic dosage of 1 g in tablet form or in water-dissolved form. To compare the role of local diffusion of the drug with its systemic availability, we also determined the corresponding concentrations in serum.
MATERUILS AND METHODS
Eight healthy volunteers (seven females, one male; ages, 18 to 42 years) took part in the study after giving informed consent. The protocol was approved by the ethics committee * Corresponding author.
of the University of Dusseldorf. Four volunteers participated twice, once with a tablet, and once with the waterdissolved form, defined as "Tabs," at an interval of more than 7 days.
Six subjects each received a tablet containing 1 g of amoxicillin (Amoxypen; Grunenthal GmbH, Stolberg, Germany) with a glass of water (ca. 50 ml) (group 1); in the second part of the study, six subjects each took the same amount of the drug dissolved in 50 ml of water, which gave an effervescent drink (Amoxypen Tabs; Grunenthal GmbH) (group 2). At 30, 60, and 90 min after ingestion of the drug, gastroscopy was performed and each time two biopsies were taken from the mucosa of the antrum, corpus, and fundus. After a biopsy had been taken, the pincers were rinsed thoroughly with sterile water. The combined weight of two biopsies from each region was measured without delay in preweighed Eppendorf caps, and the weights varied between 7.4 and 16.6 mg.
Microbiology. Amoxicillin concentrations were measured by the agar diffusion method with cavity inoculation of the ground biopsy with Bacillus subtilis (ATCC 6633) as the biological indicator and reference drug concentrations between 0.25 and 8.0 ,ug/ml (27) 
RESULTS
Amoxicillin concentrations in gastric mucosa. Irrespective of location and application form, the highest concentrations of amoxicillin were measured in biopsy samples taken at 30 min (Fig. 1) ; drug levels were significantly higher in the antrum than in the corpus or fundus. After 60 and 90 min, all levels were below the MBC90 of 0.25 ,uglmg, except for one subject in whom bactericidal levels in the antrum and fundus were observed 60 min after intake of the tablet form.
In two subjects in group 1 and five subjects in group 2, bactericidal levels in the antrum were found at 30 min (Table  1) . Only after ingestion of the tablet form were bactericidal levels reached in the fundus in two subjects (at 30 min in subject 5 and at 60 min in subject 6). After intake of both the tablets and the Tabs, most amoxicillin levels in the corpus and fundus were far below the MBC.). The benefit from elimination of the bacterium from the gastric mucosa, but early recolonization is a major problem of current therapeutic regimens (21, 25, 26) . The recolonization rate after monotherapy with bismuth salts or amoxicillin is about 60 to 70% within 4 weeks (25) . Superior results were reported after treatment with a combination of two or more antibiotic drugs, especially after triple therapy including, e.g., metronidazole, amoxicillin, and bismuth subcitrate (3). Except for treatment of duodenal ulcer disease that had been resistant to conventional therapy, the risks of possible toxicity, side effects, and development of bacterial drug resistance do not justify the widespread use of antibiotic combinations for relatively harmless conditions such as antral gastritis, especially since there controversy about the clinical relevance of gastritis in nonulcer dyspepsia remains (10, 14, 17, 26) .
The reason for early recolonization after therapy has not Amoxicillin is a generally well-tolerated antibiotic drug with good in vitro activity against H. pylon and has therefore been used in many clinical trials aimed at eradication of the bacterium from the gastric mucosa (11, 22, 25) . However, the results of these trials were disappointing because of rapid bacterial recolonization. The results obtained with amoxicillin given in combination with bismuth salts were only slightly better (25) . The usual application form of the drug is a tablet, containing 750 or 1,000 mg of the active substance, given undissolved at a dosage of about 3 g daily. The tablet form, however, may cause inhomogeneous distribution of the drug in the mucosa. For this reason, we compared it with Tabs which were dissolved in water to form a fizzing drink before ingestion.
Our results show that 30 min after oral intake of 1 g of amoxicillin in tablet form, drug concentrations in the antral mucosa were subbactericidal in four of six subjects and were above the MBC9E in only two volunteers. However, H. pylon can also be isolated from the mucosa of the gastric corpus and fundus in patients with chronic antral gastritis (7). In these regions, drug levels were far below bactericidal concentrations and often hardly detectable. In the fundus and corpus, bactericidal concentrations were reached in two subjects and one subject, respectively. The results obtained with the same dosage of the soluble form (Tabs) of amoxicillin were significantly better, reaching bactericidal levels in the antral mucosa in five of six subjects 30 min after intake. Drug concentrations in the corpus and fundus were subbactericidal in all but two cases (corpus) and did not differ significantly from those measured with the tablet form.
Biopsy specimens may contain up to 80% cellular fluid. It might therefore be argued that the drug concentrations measured in this study were artificially low because of dilution of the drug with drug-free intracellular water. As ,-lactam antibiotics do not penetrate well into the intracellular space, the measured concentrations should be multiplied by a maximum factor of 5 to correct for this effect. We believe, however, that this dilution factor is of little practical relevance. Normal mucosal biopsies are about 1.5 to 2 mm in diameter, with a depth of 200 to 300 nm (2a) , and the mucus layer covering the mucosa has a thickness of 50 to 450 ,um (mean, 180 ,m) (1). As a consequence, on average, ca. 50% of the volume of a gastric mucosal biopsy consists of mucus and the remaining 50% is mucosal tissue, reducing the dilution factor due to cellular fluid to less than 40%. Moreover, not all cells of a biopsy specimen are in lysis after grinding, reducing the dilution factor further.
Even with a dilution factor of 80%, the estimated concentrations are below the MBC90 or at the bactericidal level in most of the cases only at 30 min. While the actual dilution factor might be much less (<40%), this potential artifact would not considerably alter the results and would consequently have no impact on our conclusions. In all of the subjects, the drug levels in the mucosa were highest 30 min after oral intake, independently of the application form and the location in the stomach. The lowest concentrations were measured at 90 min, and most of them were hardly detectable. Concentrations in serum, on the other hand, were very low or not detectable at 15 min and then rose continuously to reach a maximum after 75 min. Therefore, we assume that the amoxicillin concentrations we measured in the mucosa were the result of local diffusion; this also suggests that systemic distribution of amoxicillin is of little importance for its activity against H. pylon.
Accordingly, inhomogeneous local distribution and poor systemic availability at the site of desired action may contribute considerably to the unsatisfactory results of amoxicillin therapy with respect to long-term bacterial clearance. Little work has been done to investigate the importance of the galenic form for treatment of H. pylon gastritis. Our results suggest that we need more information on the local availability of antibiotics in the gastric mucosa and that we should look for galenic forms other than tablets to improve the results of anti-H. pylon treatment.
In conclusion, our data show that the dissolved form of amoxicillin is superior to the tablet form with regard to drug concentrations in the antrum. With the tablet form, subbactericidal levels in the antral mucosa may explain the persistence of H. pylon after amoxicillin monotherapy. With a dosage of 1 g, given as a tablet or in the dissolved form, concentrations remain far below the required bactericidal levels in the mucosa of the corpus and fundus. This makes a reservoir function of these parts of the stomach for H. pylon likely. Further studies with, e.g., higher dosages of the dissolved form with monitoring of concentrations in the mucosa are therefore needed to find a solid basis for future therapeutic trials aimed at eradication of H. pylori.
